Unilateral thyroid cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Age = 18 years old, gender not limited. ? The pathological type is papillary thyroid carcinoma The maximum diameter of the tumor is less than 4cm (T1~2). ? There is no extraglandular invasion, or only a small extraglandular invasion lesion that breaks through the anterior capsule of the thyroid gland, or a small invasion of the sternal thyroid muscle CN0 or cN+stage, but the metastatic lymph nodes are not fused or fixed to each other. ? For those without obvious surgical contraindications, it is suitable to undergo axillary or clavicular endoscopic thyroidectomy for thyroid cancer. ? Able to comply with research visit plans and other protocol requirements. ? Voluntarily participate and sign an informed consent form.
Exclusion criteria
Exclusion criteria: ? Patients with internal medicine diseases and severe comorbidities who cannot tolerate general anesthesia or conventional surgical positions Previous history of neck surgery, radiotherapy, or thermal ablation treatment on the affected side Hyperthyroidism with concomitant third degree enlargement and retrosternal goiter. ? Thyroid papillary carcinoma shows obvious extraglandular invasion, such as invasion of the recurrent laryngeal nerve, larynx, trachea, esophagus, etc Thyroid papillary carcinoma with lymph node fusion fixation and lymph node metastasis in the upper mediastinum. ? Dedifferentiated thyroid cancer, clearly identified as poor prognosis pathological subtype of papillary thyroid carcinoma. ? Thyroid papillary carcinoma combined with severe thyroiditis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gender;serum calcium;parathyroid hormone;Surgical duration;Total drainage flow rate of drainage tube;Whether there is extraglandular invasion;Number of detected lymph nodes in the central region;Are there any postoperative complications;Incision pain score VAS;Neck injury index;Dysphagia index;The incidence of muscle edema;Tumor recurrence situation;Incision satisfaction;Postoperative quality of life evaluation;Satisfaction with cosmetic effects 12 months after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Name;gender;Serum free T3;Serum free T4;Serum TSH;Intraoperative bleeding volume;hospital stay;Drainage tube retention time;Position of glandular lobe;Single or multiple lesions;Maximum diameter of tumor; | — |
Countries
China
Contacts
Harbin Medical University Affiliated Second Hospital